Current Assets Alterar Data
Acadia Pharmaceuticals USD 499.17M 6.54M 2023-09
Agios Pharmaceuticals USD 704.35M 52.89M 2023-09
Alnylam Pharmaceuticals USD 2.99B 461.4M 2023-09
Arrowhead Research USD 419.52M 50.64M 2023-09
AstraZeneca USD 22.5B 338M 2023-09
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Enanta Pharmaceuticals USD 422.79M 25.67M 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Halozyme Therapeutics USD 879.01M 113.26M 2023-09
Heron Therapeutics USD 193.98M 28.7M 2023-09
Insmed USD 926.58M 125.85M 2023-09
Ligand Pharmaceuticals USD 257.76M 18.95M 2023-09
Minerva Neurosciences USD 48.22M 4M 2023-09
Moderna USD 10.8B 200M 2023-09
PTC Therapeutics USD 540.36M 49.33M 2023-09
Takeda JPY 2.46T 9.95B 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vanda Pharmaceuticals USD 533.5M 203K 2023-06
Veracyte USD 271.16M 11.68M 2023-09



Vanda Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.